188 related articles for article (PubMed ID: 25041123)
1. Valnoctamide, a non-teratogenic amide derivative of valproic acid, inhibits arachidonic acid activation in vitro by recombinant acyl-CoA synthetase-4.
Modi HR; Basselin M; Rapoport SI
Bipolar Disord; 2014 Dec; 16(8):875-80. PubMed ID: 25041123
[TBL] [Abstract][Full Text] [Related]
2. Propylisopropylacetic acid (PIA), a constitutional isomer of valproic acid, uncompetitively inhibits arachidonic acid acylation by rat acyl-CoA synthetase 4: a potential drug for bipolar disorder.
Modi HR; Basselin M; Taha AY; Li LO; Coleman RA; Bialer M; Rapoport SI
Biochim Biophys Acta; 2013 Apr; 1831(4):880-6. PubMed ID: 23354024
[TBL] [Abstract][Full Text] [Related]
3. Valproate uncompetitively inhibits arachidonic acid acylation by rat acyl-CoA synthetase 4: relevance to valproate's efficacy against bipolar disorder.
Shimshoni JA; Basselin M; Li LO; Coleman RA; Rapoport SI; Modi HR
Biochim Biophys Acta; 2011 Mar; 1811(3):163-9. PubMed ID: 21184843
[TBL] [Abstract][Full Text] [Related]
4. Valnoctamide, which reduces rat brain arachidonic acid turnover, is a potential non-teratogenic valproate substitute to treat bipolar disorder.
Modi HR; Ma K; Chang L; Chen M; Rapoport SI
Psychiatry Res; 2017 Aug; 254():279-283. PubMed ID: 28500975
[TBL] [Abstract][Full Text] [Related]
5. Lithium and the other mood stabilizers effective in bipolar disorder target the rat brain arachidonic acid cascade.
Rapoport SI
ACS Chem Neurosci; 2014 Jun; 5(6):459-67. PubMed ID: 24786695
[TBL] [Abstract][Full Text] [Related]
6. Valproic acid selectively inhibits conversion of arachidonic acid to arachidonoyl-CoA by brain microsomal long-chain fatty acyl-CoA synthetases: relevance to bipolar disorder.
Bazinet RP; Weis MT; Rapoport SI; Rosenberger TA
Psychopharmacology (Berl); 2006 Jan; 184(1):122-9. PubMed ID: 16344985
[TBL] [Abstract][Full Text] [Related]
7. Role of acyl-CoA synthetase ACSL4 in arachidonic acid metabolism.
Kuwata H; Hara S
Prostaglandins Other Lipid Mediat; 2019 Oct; 144():106363. PubMed ID: 31306767
[TBL] [Abstract][Full Text] [Related]
8. Long-chain acyl-CoA synthetase 4 participates in the formation of highly unsaturated fatty acid-containing phospholipids in murine macrophages.
Kuwata H; Nakatani E; Shimbara-Matsubayashi S; Ishikawa F; Shibanuma M; Sasaki Y; Yoda E; Nakatani Y; Hara S
Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Nov; 1864(11):1606-1618. PubMed ID: 31376475
[TBL] [Abstract][Full Text] [Related]
9. Stereoselective anticonvulsant and pharmacokinetic analysis of valnoctamide, a CNS-active derivative of valproic acid with low teratogenic potential.
Shekh-Ahmad T; Hen N; Yagen B; McDonough JH; Finnell RH; Wlodarczyk BJ; Bialer M
Epilepsia; 2014 Feb; 55(2):353-61. PubMed ID: 24313671
[TBL] [Abstract][Full Text] [Related]
10. Functional interaction between acyl-CoA synthetase 4, lipooxygenases and cyclooxygenase-2 in the aggressive phenotype of breast cancer cells.
Maloberti PM; Duarte AB; Orlando UD; Pasqualini ME; Solano AR; López-Otín C; Podestá EJ
PLoS One; 2010 Nov; 5(11):e15540. PubMed ID: 21085606
[TBL] [Abstract][Full Text] [Related]
11. Chronic carbamazepine decreases the incorporation rate and turnover of arachidonic acid but not docosahexaenoic acid in brain phospholipids of the unanesthetized rat: relevance to bipolar disorder.
Bazinet RP; Rao JS; Chang L; Rapoport SI; Lee HJ
Biol Psychiatry; 2006 Mar; 59(5):401-7. PubMed ID: 16182257
[TBL] [Abstract][Full Text] [Related]
12. Chronic valproate treatment decreases the in vivo turnover of arachidonic acid in brain phospholipids: a possible common effect of mood stabilizers.
Chang MC; Contreras MA; Rosenberger TA; Rintala JJ; Bell JM; Rapoport SI
J Neurochem; 2001 May; 77(3):796-803. PubMed ID: 11331408
[TBL] [Abstract][Full Text] [Related]
13. Role of long-chain acyl-coenzyme A synthetases in the regulation of arachidonic acid metabolism in interleukin 1β-stimulated rat fibroblasts.
Kuwata H; Yoshimura M; Sasaki Y; Yoda E; Nakatani Y; Kudo I; Hara S
Biochim Biophys Acta; 2014 Jan; 1841(1):44-53. PubMed ID: 24095834
[TBL] [Abstract][Full Text] [Related]
14. Analysis on the Substrate Specificity of Recombinant Human Acyl-CoA Synthetase ACSL4 Variants.
Shimbara-Matsubayashi S; Kuwata H; Tanaka N; Kato M; Hara S
Biol Pharm Bull; 2019; 42(5):850-855. PubMed ID: 31061331
[TBL] [Abstract][Full Text] [Related]
15. Tyrosine phosphatase SHP2 regulates the expression of acyl-CoA synthetase ACSL4.
Cooke M; Orlando U; Maloberti P; Podestá EJ; Cornejo Maciel F
J Lipid Res; 2011 Nov; 52(11):1936-48. PubMed ID: 21903867
[TBL] [Abstract][Full Text] [Related]
16. Regulation and role of Acyl-CoA synthetase 4 in glial cells.
Dattilo MA; Benzo Y; Herrera LM; Prada JG; Lopez PF; Caruso CM; Lasaga M; García CI; Paz C; Maloberti PM
J Steroid Biochem Mol Biol; 2021 Apr; 208():105792. PubMed ID: 33246155
[TBL] [Abstract][Full Text] [Related]
17. Myeloid-Specific Deficiency of
Reeves AR; Sansbury BE; Pan M; Han X; Spite M; Greenberg AS
J Immunol; 2021 Dec; 207(11):2744-2753. PubMed ID: 34725110
[TBL] [Abstract][Full Text] [Related]
18. A role for long-chain acyl-CoA synthetase-4 (ACSL4) in diet-induced phospholipid remodeling and obesity-associated adipocyte dysfunction.
Killion EA; Reeves AR; El Azzouny MA; Yan QW; Surujon D; Griffin JD; Bowman TA; Wang C; Matthan NR; Klett EL; Kong D; Newman JW; Han X; Lee MJ; Coleman RA; Greenberg AS
Mol Metab; 2018 Mar; 9():43-56. PubMed ID: 29398618
[TBL] [Abstract][Full Text] [Related]
19. Arachidonic acid downregulates acyl-CoA synthetase 4 expression by promoting its ubiquitination and proteasomal degradation.
Kan CF; Singh AB; Stafforini DM; Azhar S; Liu J
J Lipid Res; 2014 Aug; 55(8):1657-67. PubMed ID: 24879802
[TBL] [Abstract][Full Text] [Related]
20. Teratogenicity of valproic acid and its constitutional isomer, amide derivative valnoctamide in mice.
Lin YL; Bialer M; Cabrera RM; Finnell RH; Wlodarczyk BJ
Birth Defects Res; 2019 Aug; 111(14):1013-1023. PubMed ID: 30325584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
